Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) are widely involved in the expression of genomic instability in renal cell carcinoma. But no studies h...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 728181
Main Authors Fang, Xisheng, Liu, Xia, Lu, Lin, Liu, Guolong
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 05.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Renal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) are widely involved in the expression of genomic instability in renal cell carcinoma. But no studies have identified the genome instability-related lncRNAs (GInLncRNAs) and their clinical significances in RCC. Clinical data, gene expression data and mutation data of 943 RCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Based on the mutation data and lncRNA expression data, GInLncRNAs were screened out. Co-expression analysis, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were conducted to explore their potential functions and related signaling pathways. A prognosis model was further constructed based on genome instability-related lncRNAs signature (GInLncSig). And the efficiency of the model was verified by receiver operating characteristic (ROC) curve. The relationships between the model and clinical information, prognosis, mutation number and gene expression were analyzed using correlation prognostic analysis. Finally, the prognostic model was verified in clinical stratification according to TCGA dataset. A total of 45 GInLncRNAs were screened out. Functional analysis showed that the functional genes of these GInLncRNAs were mainly enriched in chromosome and nucleoplasmic components, DNA binding in molecular function, transcription and complex anabolism in biological processes. Univariate and Multivariate Cox analyses further screened out 11 GInLncSig to construct a prognostic model (AL031123.1, AC114803.1, AC103563.7, AL031710.1, LINC00460, AC156455.1, AC015977.2, 'PRDM16-dt', AL139351.1, AL035661.1 and LINC01606), and the coefficient of each GInLncSig in the model was calculated. The area under the curve (AUC) value of the ROC curve was 0.770. Independent analysis of the model showed that the GInLncSig model was significantly correlated with the RCC patients' overall survival. Furthermore, the GInLncSig model still had prognostic value in different subgroups of RCC patients. Our study preliminarily explored the relationship between genomic instability, lncRNA and clinical characteristics of RCC patients, and constructed a GInLncSig model consisted of 11 GInLncSig to predict the prognosis of patients with RCC. At the same time, our study provided theoretical support for the exploration of the formation and development of RCC.
AbstractList Renal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) are widely involved in the expression of genomic instability in renal cell carcinoma. But no studies have identified the genome instability-related lncRNAs (GInLncRNAs) and their clinical significances in RCC. Clinical data, gene expression data and mutation data of 943 RCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Based on the mutation data and lncRNA expression data, GInLncRNAs were screened out. Co-expression analysis, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were conducted to explore their potential functions and related signaling pathways. A prognosis model was further constructed based on genome instability-related lncRNAs signature (GInLncSig). And the efficiency of the model was verified by receiver operating characteristic (ROC) curve. The relationships between the model and clinical information, prognosis, mutation number and gene expression were analyzed using correlation prognostic analysis. Finally, the prognostic model was verified in clinical stratification according to TCGA dataset. A total of 45 GInLncRNAs were screened out. Functional analysis showed that the functional genes of these GInLncRNAs were mainly enriched in chromosome and nucleoplasmic components, DNA binding in molecular function, transcription and complex anabolism in biological processes. Univariate and Multivariate Cox analyses further screened out 11 GInLncSig to construct a prognostic model (AL031123.1, AC114803.1, AC103563.7, AL031710.1, LINC00460, AC156455.1, AC015977.2, 'PRDM16-dt', AL139351.1, AL035661.1 and LINC01606), and the coefficient of each GInLncSig in the model was calculated. The area under the curve (AUC) value of the ROC curve was 0.770. Independent analysis of the model showed that the GInLncSig model was significantly correlated with the RCC patients' overall survival. Furthermore, the GInLncSig model still had prognostic value in different subgroups of RCC patients. Our study preliminarily explored the relationship between genomic instability, lncRNA and clinical characteristics of RCC patients, and constructed a GInLncSig model consisted of 11 GInLncSig to predict the prognosis of patients with RCC. At the same time, our study provided theoretical support for the exploration of the formation and development of RCC.
BackgroundRenal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) are widely involved in the expression of genomic instability in renal cell carcinoma. But no studies have identified the genome instability-related lncRNAs (GInLncRNAs) and their clinical significances in RCC.MethodsClinical data, gene expression data and mutation data of 943 RCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Based on the mutation data and lncRNA expression data, GInLncRNAs were screened out. Co-expression analysis, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were conducted to explore their potential functions and related signaling pathways. A prognosis model was further constructed based on genome instability-related lncRNAs signature (GInLncSig). And the efficiency of the model was verified by receiver operating characteristic (ROC) curve. The relationships between the model and clinical information, prognosis, mutation number and gene expression were analyzed using correlation prognostic analysis. Finally, the prognostic model was verified in clinical stratification according to TCGA dataset.ResultsA total of 45 GInLncRNAs were screened out. Functional analysis showed that the functional genes of these GInLncRNAs were mainly enriched in chromosome and nucleoplasmic components, DNA binding in molecular function, transcription and complex anabolism in biological processes. Univariate and Multivariate Cox analyses further screened out 11 GInLncSig to construct a prognostic model (AL031123.1, AC114803.1, AC103563.7, AL031710.1, LINC00460, AC156455.1, AC015977.2, ‘PRDM16-dt’, AL139351.1, AL035661.1 and LINC01606), and the coefficient of each GInLncSig in the model was calculated. The area under the curve (AUC) value of the ROC curve was 0.770. Independent analysis of the model showed that the GInLncSig model was significantly correlated with the RCC patients’ overall survival. Furthermore, the GInLncSig model still had prognostic value in different subgroups of RCC patients.ConclusionOur study preliminarily explored the relationship between genomic instability, lncRNA and clinical characteristics of RCC patients, and constructed a GInLncSig model consisted of 11 GInLncSig to predict the prognosis of patients with RCC. At the same time, our study provided theoretical support for the exploration of the formation and development of RCC.
Background Renal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) are widely involved in the expression of genomic instability in renal cell carcinoma. But no studies have identified the genome instability-related lncRNAs (GInLncRNAs) and their clinical significances in RCC. Methods Clinical data, gene expression data and mutation data of 943 RCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Based on the mutation data and lncRNA expression data, GInLncRNAs were screened out. Co-expression analysis, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were conducted to explore their potential functions and related signaling pathways. A prognosis model was further constructed based on genome instability-related lncRNAs signature (GInLncSig). And the efficiency of the model was verified by receiver operating characteristic (ROC) curve. The relationships between the model and clinical information, prognosis, mutation number and gene expression were analyzed using correlation prognostic analysis. Finally, the prognostic model was verified in clinical stratification according to TCGA dataset. Results A total of 45 GInLncRNAs were screened out. Functional analysis showed that the functional genes of these GInLncRNAs were mainly enriched in chromosome and nucleoplasmic components, DNA binding in molecular function, transcription and complex anabolism in biological processes. Univariate and Multivariate Cox analyses further screened out 11 GInLncSig to construct a prognostic model (AL031123.1, AC114803.1, AC103563.7, AL031710.1, LINC00460, AC156455.1, AC015977.2, ‘PRDM16-dt’, AL139351.1, AL035661.1 and LINC01606), and the coefficient of each GInLncSig in the model was calculated. The area under the curve (AUC) value of the ROC curve was 0.770. Independent analysis of the model showed that the GInLncSig model was significantly correlated with the RCC patients’ overall survival. Furthermore, the GInLncSig model still had prognostic value in different subgroups of RCC patients. Conclusion Our study preliminarily explored the relationship between genomic instability, lncRNA and clinical characteristics of RCC patients, and constructed a GInLncSig model consisted of 11 GInLncSig to predict the prognosis of patients with RCC. At the same time, our study provided theoretical support for the exploration of the formation and development of RCC.
BACKGROUNDRenal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) are widely involved in the expression of genomic instability in renal cell carcinoma. But no studies have identified the genome instability-related lncRNAs (GInLncRNAs) and their clinical significances in RCC. METHODSClinical data, gene expression data and mutation data of 943 RCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Based on the mutation data and lncRNA expression data, GInLncRNAs were screened out. Co-expression analysis, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were conducted to explore their potential functions and related signaling pathways. A prognosis model was further constructed based on genome instability-related lncRNAs signature (GInLncSig). And the efficiency of the model was verified by receiver operating characteristic (ROC) curve. The relationships between the model and clinical information, prognosis, mutation number and gene expression were analyzed using correlation prognostic analysis. Finally, the prognostic model was verified in clinical stratification according to TCGA dataset. RESULTSA total of 45 GInLncRNAs were screened out. Functional analysis showed that the functional genes of these GInLncRNAs were mainly enriched in chromosome and nucleoplasmic components, DNA binding in molecular function, transcription and complex anabolism in biological processes. Univariate and Multivariate Cox analyses further screened out 11 GInLncSig to construct a prognostic model (AL031123.1, AC114803.1, AC103563.7, AL031710.1, LINC00460, AC156455.1, AC015977.2, 'PRDM16-dt', AL139351.1, AL035661.1 and LINC01606), and the coefficient of each GInLncSig in the model was calculated. The area under the curve (AUC) value of the ROC curve was 0.770. Independent analysis of the model showed that the GInLncSig model was significantly correlated with the RCC patients' overall survival. Furthermore, the GInLncSig model still had prognostic value in different subgroups of RCC patients. CONCLUSIONOur study preliminarily explored the relationship between genomic instability, lncRNA and clinical characteristics of RCC patients, and constructed a GInLncSig model consisted of 11 GInLncSig to predict the prognosis of patients with RCC. At the same time, our study provided theoretical support for the exploration of the formation and development of RCC.
Author Lu, Lin
Fang, Xisheng
Liu, Guolong
Liu, Xia
AuthorAffiliation 2 Department of Medical Oncology, Guangzhou First People’s Hospital, Guangzhou Medical University , Guangzhou , China
1 Department of Medical Oncology, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology , Guangzhou , China
AuthorAffiliation_xml – name: 2 Department of Medical Oncology, Guangzhou First People’s Hospital, Guangzhou Medical University , Guangzhou , China
– name: 1 Department of Medical Oncology, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology , Guangzhou , China
Author_xml – sequence: 1
  givenname: Xisheng
  surname: Fang
  fullname: Fang, Xisheng
  organization: Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
– sequence: 2
  givenname: Xia
  surname: Liu
  fullname: Liu, Xia
  organization: Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
– sequence: 3
  givenname: Lin
  surname: Lu
  fullname: Lu, Lin
  organization: Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
– sequence: 4
  givenname: Guolong
  surname: Liu
  fullname: Liu, Guolong
  organization: Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34676164$$D View this record in MEDLINE/PubMed
BookMark eNpVUk1v3CAQRVWqJk1z76ni2Iu35sMYXypF2zZdaZNKSSv1hsZ42BLZkII3Uvrry2aTKOEAw_DeA2beW3IQYkBC3rN6IYTuPrkY7ILXnC1arplmr8gR50JWnRS_D57Fh-Qk5-u6DNXUrBZvyKGQqlVMySPybzVgmL3zFmYfA42OAr2KU9lZer6d77PVF0z-Fge6jmFDL0piGQdfwsuLU3rlNwHmbcK8I59hiFOhrkKeofejn--oD_QSA4x0iWOZIFlfQPCOvHYwZjx5WI_Jr29ffy6_V-sfZ6vl6bqyUvG5UnZAjgIERweNE71y2DDRtG2Hzvauda5WWmuU2NmuZ50beuy1bVxb28IRx2S11x0iXJub5CdIdyaCN_eJmDYGUvnuiEZ2qlfgGsdYLyXrQEgQg0AGoFsuVNH6vNe62fYTDrbULsH4QvTlSfB_zCbeGt1w0fG6CHx8EEjx7xbzbCafbakLBIzbbHijpSztFW2B1nuoTTHnhO7pGlabnQPMzgFm5wCzd0ChfHj-vCfCY7_Ff-EasXU
CitedBy_id crossref_primary_10_3389_fonc_2022_997525
crossref_primary_10_1002_ctm2_1023
crossref_primary_10_1016_j_prp_2024_155255
crossref_primary_10_3389_fonc_2022_844642
crossref_primary_10_3390_ijms242316600
crossref_primary_10_3389_fphar_2022_937531
Cites_doi 10.26355/eurrev_201802_14382
10.1080/21655979.2021.1924555
10.3389/fcell.2021.657667
10.1111/j.1440-1843.2011.01972.x
10.1016/j.biocel.2018.08.012
10.1038/s41585-019-0195-1
10.3390/cancers13061267
10.3389/fonc.2021.617383
10.1042/BSR20171019
10.2147/CMAR.S192452
10.4172/2157-2518.1000165
10.1016/j.gene.2017.10.006
10.3389/fonc.2021.607595
10.7150/ijms.50704
10.1038/s41586-020-1943-3
10.1073/pnas.0406351101
10.3390/cancers13061331
10.1016/S0090-4295(01)01207-9
10.1097/PPO.0000000000000055
10.1111/j.1442-2042.2009.02319.x
10.1038/s41556-021-00666-1
10.1152/ajpcell.00459.2019
10.21037/tgh.2018.06.04
10.1089/dna.2018.4462
10.1016/j.gene.2018.10.058
10.1186/s13045-021-01059-5
10.1007/s11010-021-04076-7
10.1158/1078-0432.CCR-20-4707
10.1136/postgradmedj-2019-137172
10.1016/j.rmcr.2021.101388
10.1007/s00120-009-1960-1
10.26355/eurrev_202103_25255
10.18632/aging.103580
10.3816/CGC.2006.n.038
10.1146/annurev-genet-111212-133232
10.1186/s12935-020-01242-7
10.1002/onco.13736
10.18632/oncotarget.24027
10.7150/jca.26046
10.1016/j.cell.2018.07.034
10.1111/j.1464-410X.2003.04505.x
10.3390/genes10060407
10.1186/s13148-021-01084-8
10.1016/j.cell.2015.12.017
10.1038/s41568-020-0290-x
10.1016/j.canlet.2018.01.060
10.1158/1078-0432.CCR-04-0488
10.3322/caac.21551
10.1016/j.ebiom.2015.09.012
10.1016/j.tox.2017.07.014
10.3389/fmolb.2021.623120
10.1016/j.cell.2018.11.024
10.1016/j.omtn.2018.06.012
10.1111/bju.15415
10.1038/cdd.2017.74
10.3390/cancers13040859
10.1097/01.ju.0000154351.37249.f0
10.3389/fcell.2021.618987
10.1016/j.urolonc.2020.08.028
10.3389/fonc.2019.01048
ContentType Journal Article
Copyright Copyright © 2021 Fang, Liu, Lu and Liu.
Copyright © 2021 Fang, Liu, Lu and Liu 2021 Fang, Liu, Lu and Liu
Copyright_xml – notice: Copyright © 2021 Fang, Liu, Lu and Liu.
– notice: Copyright © 2021 Fang, Liu, Lu and Liu 2021 Fang, Liu, Lu and Liu
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fonc.2021.728181
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
EndPage 728181
ExternalDocumentID oai_doaj_org_article_496b6af5f11b4419a34a3d3e1aa87236
10_3389_fonc_2021_728181
34676164
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c462t-6cde2e3a32efa5f3b6fe5135779efcbf7ff06888e4e9c9b19fdbeb8c5f70c2ef3
IEDL.DBID RPM
ISSN 2234-943X
IngestDate Tue Oct 22 15:15:34 EDT 2024
Tue Sep 17 21:14:56 EDT 2024
Fri Oct 25 08:49:17 EDT 2024
Thu Sep 26 16:09:24 EDT 2024
Sat Sep 28 08:23:20 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords genome instability-related lncRNAs (GInLncRNAs)
renal cell carcinoma
lncRNA
prognostic risk model
genomic instability
Language English
License Copyright © 2021 Fang, Liu, Lu and Liu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-6cde2e3a32efa5f3b6fe5135779efcbf7ff06888e4e9c9b19fdbeb8c5f70c2ef3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors have contributed equally to this work
Edited by: Antonio Augusto Ornellas, National Cancer Institute (INCA), Brazil
This article was submitted to Genitourinary Oncology, a section of the journal Frontiers in Oncology
Reviewed by: Maria Helena Ornellas, Universidade Estadual do Rio de Janeiro, Brazil; Claudia A. S. Lage, Federal University of Rio de Janeiro, Brazil
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523920/
PMID 34676164
PQID 2584433837
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_496b6af5f11b4419a34a3d3e1aa87236
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8523920
proquest_miscellaneous_2584433837
crossref_primary_10_3389_fonc_2021_728181
pubmed_primary_34676164
PublicationCentury 2000
PublicationDate 2021-10-05
PublicationDateYYYYMMDD 2021-10-05
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-05
  day: 05
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in oncology
PublicationTitleAlternate Front Oncol
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Harshman (B9) 2014; 20
Dionellis (B16) 2021; 13
Klimaszewska-Wiśniewska (B19) 2021; 13
Zhai (B32) 2017; 24
Yang (B12) 2021; 14
Guo (B30) 2021; 320
Joosten (B45) 2021; 13
Ma (B55) 2019; 38
Martinez-Jimenez (B23) 2020; 20
Raghuram (B25) 2019; 10
Yue (B57) 2018; 22
Gao (B13) 2021; 9
Aguilera (B26) 2013; 47
Flippot (B8) 2019; 16
Qin (B39) 2021; 18
Lee (B29) 2016; 164
Yao (B21) 2014; 5
Putra (B33) 2011; 16
Wang (B54) 2018; 9
Sihag (B27) 2021; 27
Aguilar-Mahecha (B15) 2021; 13
Zimta (B60) 2019; 9
Jiang (B48) 2020; 20
Zhang (B53) 2019; 11
Pascale (B34) 2018; 3
Thompson (B11) 2006; 5
Ohlmann (B42) 2009; 48
Acharya (B7) 2021; 476
Kim (B41) 2015; 2
Dai (B58) 2020; 96
Kong (B50) 2018; 639
Kim (B37) 2005; 173
Luo (B59) 2018; 103
Alexandrov (B24) 2020; 578
May (B36) 2009; 16
Siegel (B1) 2019; 69
Yang (B31) 2018; 9
Qi (B2) 2021; 11
Chu (B14) 2021; 8
Liu (B5) 2021; 11
Geng (B17) 2021; 9
Ye (B49) 2019; 685
Jachimowicz (B20) 2019; 176
Thompson (B10) 2004; 101
Lian (B52) 2018; 12
Li (B56) 2018; 420
Chan (B35) 2017; 391
Yao (B46) 2021; 25
Yaycioglu (B44) 2001; 58
Wu (B28) 2021; 12
Motazedian (B18) 2021; 23
Kim (B38) 2004; 10
Bailey (B22) 2018; 174
Cindolo (B43) 2003; 92
Paciotti (B6) 2021; 26
Abu-Ghanem (B4) 2021; 128
Saito (B3) 2021; 33
Bearrick (B40) 2021; 39
Liu (B47) 2020; 12
Liang (B51) 2017; 37
References_xml – volume: 22
  year: 2018
  ident: B57
  article-title: Effects of Linc00460 on Cell Migration and Invasion Through Regulating Epithelial-Mesenchymal Transition (EMT) in non-Small Cell Lung Cancer
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201802_14382
  contributor:
    fullname: Yue
– volume: 12
  year: 2021
  ident: B28
  article-title: Prediction of Bladder Cancer Outcome by Identifying and Validating a Mutation-Derived Genomic Instability-Associated Long Noncoding RNA (lncRNA) Signature
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1924555
  contributor:
    fullname: Wu
– volume: 9
  year: 2021
  ident: B17
  article-title: Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2021.657667
  contributor:
    fullname: Geng
– volume: 16
  start-page: 796
  year: 2011
  ident: B33
  article-title: Hypoxia-Inducible Factor-1alpha Polymorphisms are Associated With Genetic Aberrations in Lung Cancer
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2011.01972.x
  contributor:
    fullname: Putra
– volume: 103
  year: 2018
  ident: B59
  article-title: The Long non-Coding RNA LINC01606 Contributes to the Metastasis and Invasion of Human Gastric Cancer and is Associated With Wnt/beta-Catenin Signaling
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2018.08.012
  contributor:
    fullname: Luo
– volume: 16
  start-page: 484
  year: 2019
  ident: B8
  article-title: Long non-Coding RNAs in Genitourinary Malignancies: A Whole New World
  publication-title: Nat Rev Urol
  doi: 10.1038/s41585-019-0195-1
  contributor:
    fullname: Flippot
– volume: 13
  start-page: 1267
  year: 2021
  ident: B16
  article-title: Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes
  publication-title: Cancers
  doi: 10.3390/cancers13061267
  contributor:
    fullname: Dionellis
– volume: 11
  year: 2021
  ident: B2
  article-title: Safety of Prolonged Wait Time for Nephrectomy for Clinically Localized Renal Cell Carcinoma
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.617383
  contributor:
    fullname: Qi
– volume: 37
  start-page: BSR20171019
  year: 2017
  ident: B51
  article-title: A Novel Long Noncoding RNA Linc00460 Up-Regulated by CBP/P300 Promotes Carcinogenesis in Esophageal Squamous Cell Carcinoma
  publication-title: Biosci Rep
  doi: 10.1042/BSR20171019
  contributor:
    fullname: Liang
– volume: 11
  year: 2019
  ident: B53
  article-title: lncRNA LINC00460 Promoted Colorectal Cancer Cells Metastasis via miR-939-5p Sponging
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S192452
  contributor:
    fullname: Zhang
– volume: 5
  year: 2014
  ident: B21
  article-title: Genomic Instability and Cancer
  publication-title: J Carcinog Mutagen
  doi: 10.4172/2157-2518.1000165
  contributor:
    fullname: Yao
– volume: 639
  start-page: 77
  year: 2018
  ident: B50
  article-title: LncRNA-LINC00460 Facilitates Nasopharyngeal Carcinoma Tumorigenesis Through Sponging miR-149-5p to Up-Regulate IL6
  publication-title: Gene
  doi: 10.1016/j.gene.2017.10.006
  contributor:
    fullname: Kong
– volume: 11
  year: 2021
  ident: B5
  article-title: Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.607595
  contributor:
    fullname: Liu
– volume: 18
  year: 2021
  ident: B39
  article-title: Integral Analysis of the RNA Binding Protein-Associated Prognostic Model for Renal Cell Carcinoma
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.50704
  contributor:
    fullname: Qin
– volume: 578
  start-page: 94
  year: 2020
  ident: B24
  article-title: The Repertoire of Mutational Signatures in Human Cancer
  publication-title: Nature
  doi: 10.1038/s41586-020-1943-3
  contributor:
    fullname: Alexandrov
– volume: 101
  year: 2004
  ident: B10
  article-title: Costimulatory B7-H1 in Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0406351101
  contributor:
    fullname: Thompson
– volume: 13
  start-page: 1331
  year: 2021
  ident: B15
  article-title: Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer Patients
  publication-title: Cancers
  doi: 10.3390/cancers13061331
  contributor:
    fullname: Aguilar-Mahecha
– volume: 58
  year: 2001
  ident: B44
  article-title: Prognostic Assessment of Nonmetastatic Renal Cell Carcinoma: A Clinically Based Model
  publication-title: Urology
  doi: 10.1016/S0090-4295(01)01207-9
  contributor:
    fullname: Yaycioglu
– volume: 20
  year: 2014
  ident: B9
  article-title: Subverting the B7-H1/PD-1 Pathway in Advanced Melanoma and Kidney Cancer
  publication-title: Cancer J
  doi: 10.1097/PPO.0000000000000055
  contributor:
    fullname: Harshman
– volume: 16
  year: 2009
  ident: B36
  article-title: Validation of a Postoperative Prognostic Model Consisting of Tumor Microvascular Invasion, Size, and Grade to Predict Disease-Free and Cancer-Specific Survival of Patients With Surgically Resected Renal Cell Carcinoma
  publication-title: Int J Urol
  doi: 10.1111/j.1442-2042.2009.02319.x
  contributor:
    fullname: May
– volume: 23
  year: 2021
  ident: B18
  article-title: MSL Pushes Genomic Instability Over the Edge
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-021-00666-1
  contributor:
    fullname: Motazedian
– volume: 320
  year: 2021
  ident: B30
  article-title: Suppression of lncRNA HOTAIR Alleviates RCC Angiogenesis Through Regulating miR-126/EGFL7 Axis
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00459.2019
  contributor:
    fullname: Guo
– volume: 3
  start-page: 36
  year: 2018
  ident: B34
  article-title: Deregulation of Methionine Metabolism as Determinant of Progression and Prognosis of Hepatocellular Carcinoma
  publication-title: Transl Gastroenterol Hepatol
  doi: 10.21037/tgh.2018.06.04
  contributor:
    fullname: Pascale
– volume: 38
  year: 2019
  ident: B55
  article-title: Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p
  publication-title: DNA Cell Biol
  doi: 10.1089/dna.2018.4462
  contributor:
    fullname: Ma
– volume: 685
  start-page: 76
  year: 2019
  ident: B49
  article-title: LncRNA LINC00460 Promotes Tumor Growth of Human Lung Adenocarcinoma by Targeting miR-302c-5p/FOXA1 Axis
  publication-title: Gene
  doi: 10.1016/j.gene.2018.10.058
  contributor:
    fullname: Ye
– volume: 14
  start-page: 46
  year: 2021
  ident: B12
  article-title: Low Expression of TRAF3IP2-AS1 Promotes Progression of NONO-TFE3 Translocation Renal Cell Carcinoma by Stimulating N(6)-Methyladenosine of PARP1 mRNA and Downregulating PTEN
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-021-01059-5
  contributor:
    fullname: Yang
– volume: 476
  year: 2021
  ident: B7
  article-title: Differential Sensitivity of Renal Carcinoma Cells to Doxorubicin and Epigenetic Therapeutics Depends on the Genetic Background
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-021-04076-7
  contributor:
    fullname: Acharya
– volume: 27
  year: 2021
  ident: B27
  article-title: Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
  publication-title: Clin Cancer Res An Off J Am Assoc Cancer Res
  doi: 10.1158/1078-0432.CCR-20-4707
  contributor:
    fullname: Sihag
– volume: 96
  year: 2020
  ident: B58
  article-title: Prognostic Significance of LINC00460 Overexpression in Solid Tumours: A Meta-Analysis
  publication-title: Postgrad Med J
  doi: 10.1136/postgradmedj-2019-137172
  contributor:
    fullname: Dai
– volume: 33
  start-page: 101388
  year: 2021
  ident: B3
  article-title: Localized Pleural Metastasis Without Other Organ Metastases After Nephrectomy for Renal Cell Carcinoma
  publication-title: Respir Med Case Rep
  doi: 10.1016/j.rmcr.2021.101388
  contributor:
    fullname: Saito
– volume: 48
  year: 2009
  ident: B42
  article-title: Prognostic Factors for Survival of Patients With Metastatic Renal Cell Carcinoma
  publication-title: Urol A
  doi: 10.1007/s00120-009-1960-1
  contributor:
    fullname: Ohlmann
– volume: 25
  year: 2021
  ident: B46
  article-title: MicroRNA Related Prognosis Biomarkers From High Throughput Sequencing Data of Kidney Renal Papillary Cell Carcinoma
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_202103_25255
  contributor:
    fullname: Yao
– volume: 12
  year: 2020
  ident: B47
  article-title: Bioinformatics Profiling Integrating a Four Immune-Related Long Non-Coding RNAs Signature as a Prognostic Model for Papillary Renal Cell Carcinoma
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.103580
  contributor:
    fullname: Liu
– volume: 5
  year: 2006
  ident: B11
  article-title: Significance of B7-H1 Overexpression in Kidney Cancer
  publication-title: Clin Genitourin Cancer
  doi: 10.3816/CGC.2006.n.038
  contributor:
    fullname: Thompson
– volume: 47
  start-page: 1
  year: 2013
  ident: B26
  article-title: Causes of Genome Instability
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-111212-133232
  contributor:
    fullname: Aguilera
– volume: 20
  start-page: 166
  year: 2020
  ident: B48
  article-title: Bioinformatics Profiling Integrating a Three Immune-Related Long Non-Coding RNA Signature as a Prognostic Model for Clear Cell Renal Cell Carcinoma
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-020-01242-7
  contributor:
    fullname: Jiang
– volume: 26
  year: 2021
  ident: B6
  article-title: Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S
  publication-title: Oncol
  doi: 10.1002/onco.13736
  contributor:
    fullname: Paciotti
– volume: 9
  year: 2018
  ident: B31
  article-title: LncRNA LOC653786 Promotes Growth of RCC Cells via Upregulating FOXM1
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24027
  contributor:
    fullname: Yang
– volume: 9
  year: 2018
  ident: B54
  article-title: Upregulated Expression of Long Non-Coding RNA, LINC00460, Suppresses Proliferation of Colorectal Cancer
  publication-title: J Cancer
  doi: 10.7150/jca.26046
  contributor:
    fullname: Wang
– volume: 174
  year: 2018
  ident: B22
  article-title: Comprehensive Characterization of Cancer Driver Genes and Mutations
  publication-title: Cell
  doi: 10.1016/j.cell.2018.07.034
  contributor:
    fullname: Bailey
– volume: 92
  year: 2003
  ident: B43
  article-title: A Preoperative Clinical Prognostic Model for non-Metastatic Renal Cell Carcinoma
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2003.04505.x
  contributor:
    fullname: Cindolo
– volume: 10
  start-page: 407
  year: 2019
  ident: B25
  article-title: Illegitimate and Repeated Genomic Integration of Cell-Free Chromatin in the Aetiology of Somatic Mosaicism, Ageing, Chronic Diseases and Cancer
  publication-title: Genes (Basel)
  doi: 10.3390/genes10060407
  contributor:
    fullname: Raghuram
– volume: 13
  start-page: 103
  year: 2021
  ident: B45
  article-title: Development of a Prognostic Risk Model for Clear Cell Renal Cell Carcinoma by Systematic Evaluation of DNA Methylation Markers
  publication-title: Clin Epigenet
  doi: 10.1186/s13148-021-01084-8
  contributor:
    fullname: Joosten
– volume: 164
  start-page: 69
  year: 2016
  ident: B29
  article-title: Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
  publication-title: Cell
  doi: 10.1016/j.cell.2015.12.017
  contributor:
    fullname: Lee
– volume: 20
  year: 2020
  ident: B23
  article-title: A Compendium of Mutational Cancer Driver Genes
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-020-0290-x
  contributor:
    fullname: Martinez-Jimenez
– volume: 420
  start-page: 80
  year: 2018
  ident: B56
  article-title: Long non-Coding RNA Linc00460 Promotes Epithelial-Mesenchymal Transition and Cell Migration in Lung Cancer Cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.01.060
  contributor:
    fullname: Li
– volume: 10
  year: 2004
  ident: B38
  article-title: Using Protein Expressions to Predict Survival in Clear Cell Renal Carcinoma
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-04-0488
  contributor:
    fullname: Kim
– volume: 69
  start-page: 7
  year: 2019
  ident: B1
  article-title: Cancer Statistics, 2019
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21551
  contributor:
    fullname: Siegel
– volume: 2
  year: 2015
  ident: B41
  article-title: A Molecular Model for Predicting Overall Survival in Patients With Metastatic Clear Cell Renal Carcinoma: Results From CALGB 90206 (Alliance)
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2015.09.012
  contributor:
    fullname: Kim
– volume: 391
  start-page: 75
  year: 2017
  ident: B35
  article-title: Inherited Mitochondrial Genomic Instability and Chemical Exposures
  publication-title: Toxicology
  doi: 10.1016/j.tox.2017.07.014
  contributor:
    fullname: Chan
– volume: 8
  year: 2021
  ident: B14
  article-title: Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2021.623120
  contributor:
    fullname: Chu
– volume: 176
  start-page: 505
  year: 2019
  ident: B20
  article-title: UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors
  publication-title: Cell
  doi: 10.1016/j.cell.2018.11.024
  contributor:
    fullname: Jachimowicz
– volume: 12
  year: 2018
  ident: B52
  article-title: A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2018.06.012
  contributor:
    fullname: Lian
– volume: 128
  year: 2021
  ident: B4
  article-title: Should Patients With Low Risk Renal Cell Carcinoma be Followed Differently After Nephron-Sparing Surgery Versus Radical Nephrectomy
  publication-title: BJU Int
  doi: 10.1111/bju.15415
  contributor:
    fullname: Abu-Ghanem
– volume: 24
  year: 2017
  ident: B32
  article-title: LncRNA-SARCC Suppresses Renal Cell Carcinoma (RCC) Progression via Altering the Androgen Receptor(AR)/miRNA-143-3p Signals
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2017.74
  contributor:
    fullname: Zhai
– volume: 13
  start-page: 859
  year: 2021
  ident: B19
  article-title: Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma
  publication-title: Cancers
  doi: 10.3390/cancers13040859
  contributor:
    fullname: Klimaszewska-Wiśniewska
– volume: 173
  year: 2005
  ident: B37
  article-title: Using Tumor Markers to Predict the Survival of Patients With Metastatic Renal Cell Carcinoma
  publication-title: J Urol
  doi: 10.1097/01.ju.0000154351.37249.f0
  contributor:
    fullname: Kim
– volume: 9
  year: 2021
  ident: B13
  article-title: ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3beta/beta-Catenin Signaling Pathway
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2021.618987
  contributor:
    fullname: Gao
– volume: 39
  year: 2021
  ident: B40
  article-title: Creation of a Primary Tumor Tissue Expression Biomarker-Augmented Prognostic Model for Patients With Metastatic Renal Cell Carcinoma
  publication-title: Urol Oncol
  doi: 10.1016/j.urolonc.2020.08.028
  contributor:
    fullname: Bearrick
– volume: 9
  year: 2019
  ident: B60
  article-title: Long Non-Coding RNAs in Myeloid Malignancies
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.01048
  contributor:
    fullname: Zimta
SSID ssj0000650103
Score 2.347105
Snippet Renal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and genomic...
Background Renal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and...
BACKGROUNDRenal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and...
BackgroundRenal cell carcinoma (RCC) is a malignant tumor with high morbidity and mortality. It is characterized by a large number of somatic mutations and...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 728181
SubjectTerms genome instability-related lncRNAs (GInLncRNAs)
genomic instability
lncRNA
Oncology
prognostic risk model
renal cell carcinoma
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLouUVSpGRuHAITfyMj-1CqRC7h5ZKvVl24ikroQTRXST49Z2J02oXIXHhkoPjKKP5xpmZePwNY2-kwaAWmqqMDqBUdcA1p2Nbdjoa2RIjuqEDzvOFOb1Qny715UarL6oJy_TAWXGHyploAmio64iu2wWpguxkqkNorJCZbLtyG8lU_gZramCQ9yUxC3OHMPTEWCjqd5YIkOotPzTS9f8txvyzVHLD95w8Yg-noJEfZWF32b3U77H782lb_DH7nY_bwvT_jQ_AAz8fRjZWPl_n3fbyPRrbz9Txz0N_xRc4MBvIcfGzxRE_X15lis9revhjGg8rc6okyDzev_iy52eJpJilb3ihFkQ4KTxhFycfvsxOy6mpQtkqI1alabskkgxSJAgaZDSQdC21tS5BG8ECUB-aJqnkWhdrB11MsWk12KrFZ-RTttMPfXrOeFAR9dk1gWIW09kIoXUiCitUFMpWBXt7q2L_PXNneMw5CA5PcHiCw2c4CnZMGNzNI9brcQBtwU-24P9lCwV7fYugx1VCWx-hT8P62guMs9SYjRfsWUb07lUSfYXBrLFgdgvrLVm27_TLryMTd4NpvBPVi_8h_D57QPoYCwX1S7az-rFOBxjwrOKr0bZvAEM3ACs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELbQIiEuiDfhJSNx4ZCl8TM-ILQUlhWiPexSqTfLduxSaZVAH4jl1zMTZxeKeuESKY6dOB5PZiYz8w0hL7kCpTbVo9KblEpROeA56UPZSK94QER0hQnOk6k6mYlPczn_kx49LOB6r2mH9aRmq_PDn98v3gLDv0GLE-Tt69S1CEbIqkON2EZgC11nAux0DOQblP38XZZY1ACrzTEuSiP4PPst995kR071cP77dNB_Qyn_kk3Ht8mtQamkR3kX3CHXYnuX3JgMbvN75FdOx03D_znaJeroWdejtdLJNnvjy_ewGX_Ehn7u2gWdQsO4Q8FGT6dH9Gy5yBCgaxz8MfbJzBQjDTLO9wVdtvQ04izG8RwOWKIIOrn7ZHb84cv4pByKLpRBKLYpVWgii9xxFpOTiXuVoqy41NrEFHzSKWGdmjqKaILxlUmNj74OMulRgDH8ATlouzY-ItQJD-vZ1A51GtVon1wwzDPNhGdCjwry6nKJ7beMrWHBJkFyWCSHRXLYTI6CvEMaXPVDVOy-oVst7MBkVhjllUsyVZUHNc84LhxveKycqzXjqiAvLilogYvQNeLa2G3XloEeJnprvSAPM0WvHsVBliiwKguid2i9M5fdK-3ya4_UXYOZb9jo8X-86BNyE8_6eEH5lBxsVtv4DPSejX_eb-ffnSMBRA
  priority: 102
  providerName: Scholars Portal
Title Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/34676164
https://search.proquest.com/docview/2584433837
https://pubmed.ncbi.nlm.nih.gov/PMC8523920
https://doaj.org/article/496b6af5f11b4419a34a3d3e1aa87236
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJtQqIzEhUN2N34mx7LQVohdoZZKe4tsx96u1CZVu1sJfj0zdlJ1EScuPji2Yvkb2zOe8TeEfOQKlNpQTnJbhZCLwsCak9bljbSKO2REV_jAeTZXJ-fi20Iudogc3sLEoH1nV6P28mrUri5ibOX1lRsPcWLjH7NpCdZTxSbjXbILAvrARE_br8TcBcklCQZYNQ5di2SFrBhp5D7C5DAc9gdVKLF1GkXS_n9pmn8HTD44gY6ekie96kgP0xCfkR3fPiePZr1z_AX5nR7dhv4WjnaBGnrWRU5WOtskn3v-BUTuzjf0e9cu6Rwqph0eX_R0fkjPVstE9HmLnY99fLJMMZ4gsXn_oquWnnocxdRfQoGJiKCReUnOj77-nJ7kfWqF3AnF1rlyjWeeG858MDJwq4KXBZdaVz44G3QImI2m9MJXrrJFFRrrbelk0BMHffgrstd2rX9DqBEWprYpDWouqtE2GFcxyzQTlgk9ycinYYrr68SgUYPlgcjUiEyNyNQJmYx8Rgzu2yH3dazobpZ1LwG1qJRVJshQFBaUucpwYXjDfWFMqRlXGfkwIFjDWkEHiGl9t7mtGWhbItrkGXmdEL3_1SARGdFbWG-NZfsLiGfk4-7F8e1_99wnj3ESYoygfEf21jcb_x50nbU9iHcEUB4vCihnojyI0v4HIt0Dtw
link.rule.ids 230,315,730,783,787,867,888,2109,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYBLeZaGp5G4cEg28TM-loWywGaF-kC9WbZjLyvapGp3keivx46TqltxgUsOfiiOZ8aeycx8A8BbzLxS68o81cK5lBTKyxzVJq2pZtgERHQWEpyrGZsckS_H9HgD0CEXpgvaN3qRNSenWbP40cVWnp2a0RAnNvpWjUtvPQmUj26B215ec3LNSI8HMA3VC6JT0ptgYuTaJsAVoiLjAf0olIfB_oRgBSNr91EH2_83XfNmyOS1O2jvPvg-rD6GnvzMVkudmcsbwI7__HkPwFavlcLd2P0QbNjmEbhT9X73x-Ay5vO6_gcfbB1U8KDt4F5htYru_PSD5-ZftobTtpnDmW8Yt-FmhPuzXXiwmEcM0Ysw-ZPtsqFhCFWIQOG_4aKB-zasYmxP_CPUOPKD1BNwtPfxcDxJ-6oNqSEMLVNmaossVhhZp6jDmjlLC0w5F9YZ7bhzodBNaYkVRuhCuFpbXRrqeG78HLwNNpu2sTsAKqI9zepSBaWI1Vw7ZQTSiCOiEeF5At4NtJNnEZxDeqMmkFwGkstAchlJnoD3gbhX4wKsdtfQns9lv_uSCKaZctQVhfZ6olCYKFxjWyhVcoRZAt4MrCG9GAbfimpsu7qQyCtypDP3E_A0ssrVqwZWSwBfY6K1taz3eNbooL57Vnj23zNfg7uTw2oqp59nX5-De2FDulBE-gJsLs9X9qVXqZb6VSdAfwDvxSLq
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUX3pTwNBIXDnn5mRzLlqVAd1W1VKq4WLZjLyvaZNXuItFfjx9JtVtx6iUHx1bifDP2TGb8DQAfMHNGra2KVNXWpqSUTueo0mlDFcPaM6Izf8B5MmX7J-TbKT1dK_UVkva1mmft2XnWzn-F3MrFuc6HPLH8cDKqnPdUoyJfNDa_C-45nS3YmqMeF2HqKxjEwKRzw-rcdq2nLERlxj0Dki8Rg90qwUpGNvakQN3_P3vzZtrk2j40fgh-DjOI6Se_s9VSZfrqBrnjrab4CDzorVO4G7s8BndM-wRsT_r4-1NwFc_12v5HH-wslPC4C7SvcLKKYf10z0n1H9PAg66dwalrGHV-h4RH0114PJ9FLtFLP_iLCaeioU9ZiIThf-G8hUfGv8XInLmLr3XkOsln4GT8-cdoP-2rN6SaMLRMmW4MMlhiZKykFitmDS0x5bw2VivLrfUFbypDTK1rVda2UUZVmlpeaDcGPwdbbdeaFwBKohxuTSW9ccQarqzUNVKII6IQ4UUCPg74iUUk6RDOufGwCw-78LCLCHsCPnmAr_t5eu3Q0F3MRI-AIDVTTFpqy1I5e7GWmEjcYFNKWXGEWQLeD-IhnDr6GItsTbe6FMgZdCS4_QnYieJy_ahB3BLANwRp41027zjxCJTfvTi8vPXId2D7cG8sDr5Ov78C9_33CBmJ9DXYWl6szBtnWS3V26BD_wD0WSVq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+a+Somatic+Mutation-Derived+Long+Non-Coding+RNA+Signatures+of+Genomic+Instability+in+Renal+Cell+Carcinoma&rft.jtitle=Frontiers+in+oncology&rft.au=Fang%2C+Xisheng&rft.au=Liu%2C+Xia&rft.au=Lu%2C+Lin&rft.au=Liu%2C+Guolong&rft.date=2021-10-05&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=11&rft_id=info:doi/10.3389%2Ffonc.2021.728181&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fonc_2021_728181
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon